Internal Medicine · Brooklyn, NY
NPI
1154493575
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
359 Avenue U
Brooklyn, NY, 11223
Phone (718) 627-8700
Groups this clinician bills Medicare through
Medicare paid, 2024
$485K
6,563 services
Medicare patients, 2024
1,300
Average age 78
Drug cost, 2024
$3.4M
51,855 prescriptions
Company payments, 2025
$1,589
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Elie Fteha was code 99232 (hospital e&m - subsequent), 1,800 times for 334 patients. In total Elie Fteha billed 6,563 services in 43 codes, and Medicare paid $485K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,800 | 334 | $73.51 | $132K |
| 99213 Office E&M - Established | Office | 1,376 | 575 | $78.60 | $108K |
| 99308 SNF E&M | Facility | 614 | 236 | $68.19 | $42K |
| 36415 Venipuncture Blood Collection | Office | 546 | 343 | $8.65 | $4,723 |
| 99222 Hospital E&M - Initial | Facility | 413 | 342 | $122.61 | $51K |
| 99349 Home E&M - New and Established | Office | 396 | 150 | $111.36 | $44K |
| 99442 Telephone Services | Office | 188 | 146 | $79.83 | $15K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 164 | 164 | $155.12 | $25K |
| 99306 SNF E&M | Facility | 130 | 122 | $169.74 | $22K |
| G0008 Administration of influenza virus vaccine | Office | 123 | 122 | $29.78 | $3,662 |
| 90653 Vaccine Product | Office | 118 | 118 | $81.82 | $9,655 |
| 96372 Injection Administration | Office | 107 | 49 | $13.28 | $1,421 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 90 | 42 | $0.95 | $85.88 |
| 87811 Immunoassay | Office | 82 | 76 | $40.55 | $3,325 |
| 99316 SNF E&M | Facility | 79 | 78 | $122.04 | $9,641 |
By year: 2022 $401K for 6,273 services; 2023 $464K for 6,892 services; 2024 $485K for 6,563 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 546 | 343 | $8.65 | $4,723 |
| 87811 Immunoassay | 82 | 76 | $40.55 | $3,325 |
| 87804 Immunoassay | 72 | 35 | $16.22 | $1,168 |
| 81002 Clinical Chemistry | 16 | 15 | $3.41 | $54.56 |
| 87880 Immunoassay | 11 | 11 | $16.20 | $178 |
Medicare prescription drug claims, 2024
In 2024, the drug Elie Fteha prescribed most often to Medicare patients was Atorvastatin Calcium, with 3,597 prescriptions and refills. In total Elie Fteha wrote 51,855 Medicare prescriptions that cost $3.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 3,597 | 4,273 | 465 | $27K |
| Amlodipine Besylate Generic | 3,067 | 3,654 | 379 | $16K |
| Pantoprazole Sodium Generic | 1,945 | 2,160 | 253 | $18K |
| Metoprolol Tartrate Generic | 1,519 | 1,611 | 152 | $9,321 |
| Losartan Potassium Generic | 1,482 | 1,779 | 199 | $11K |
| Tamsulosin Hcl Generic | 1,457 | 1,567 | 159 | $16K |
| Gabapentin Generic | 1,417 | 1,491 | 154 | $13K |
| Mirtazapine Generic | 1,374 | 1,390 | 129 | $19K |
| Eliquis Apixaban | 1,190 | 1,222 | 144 | $432K |
| Levothyroxine Sodium Generic | 1,119 | 1,278 | 147 | $8,268 |
| Furosemide Generic | 1,067 | 1,113 | 134 | $4,662 |
| Famotidine Generic | 1,052 | 1,088 | 100 | $7,465 |
| Metoprolol Succinate Generic | 1,050 | 1,313 | 173 | $11K |
| Metformin Hcl Generic | 906 | 1,153 | 158 | $4,619 |
| Memantine Hcl Generic | 711 | 719 | 49 | $14K |
Brand drugs: 7,152 claims; generic drugs: 43,963 claims; opioid claims: 214.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Elie Fteha $1,589 ($1,589 in general payments such as food, travel and fees) from 18 companies. The largest payer was Axsome Therapeutics, Inc. with $316.
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. AXSM | 20 | $316 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $183 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 7 | $182 |
| Ardelyx, Inc. ARDX | 11 | $177 |
| Amgen Inc. AMGN | 3 | $167 |
| Novartis Pharmaceuticals Corporation NVS | 6 | $126 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $125 |
| Lundbeck LLC | 3 | $71.81 |
| Abbvie Inc. ABBV | 2 | $45.12 |
| Philips North America LLC PHG | 1 | $27.45 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.